Address : 64/2-100, ST FRANCIS XAVIER CHURCH ROAD, KATHRIKADAVU, KALOOR, COCHIN- 682017
SID No : 113025062 Patient ID : A130184230
Branch : COCHIN
Mrs. TINCY
Age / Sex : 26 Y / Female Collected Date : 28/07/2025 / 17:39
Ref. By : ECH AYURVEDA HOSPITAL - PAREMAVU Received Date : 28/07/2025 / 21:40
Reported Date : 28/07/2025 / 23:19
Final Test Report Page 1 of 1
Test Name / Specimen Result Units Reference Range / Method
IMMUNOLOGY
25 Hydroxyvitamin D 15.4 ng/ml Deficiency : <= 20
Serum Insufficiency: 21 - 29
Sufficiency : >= 30
ECLIA
Comments : Vitamin D is a fat-soluble steroid hormone precursor that is mainly produced in the skin by exposure to sunlight. Vitamin D is biologically inert and must
undergo two successive hydroxylations in the liver and kidney to become the biologically active 1,25 - dihydroxyvitamin D. It is commonly agreed that 25-
hydroxyvitamin D is the metabolite to determine the overall vitamin D status as it is the major storage form of vitamin D in the human body. This primary circulating
form of vitamin D is present human body with levels approximately 1000 fold greater than the circulating 1,25-dihydroxyvitamin D. The half-life of circulating 25-
hydroxyvitamin D is 2-3 weeks.
Vitamin D is essential for : Bone health. In children, severe deficiency leads to bone-malformation, known as rickets. Milder degrees of insufficiency are believed to
cause reduced efficiency in the utilization of dietary calcium.
Vitamin D deficiency causes : Muscle weakness in elderly, the risk of falling has been attributed to the effect of vitamin D on muscle function. Vitamin D deficiency
is a common cause of secondary hyperparathyroidism. Elevations of PTH levels, especially in elderly vitamin D deficient adults can result in osteomalacia, increased
bone turnover, reduced bone mass and risk of bone fractures. Low vitamin D (25-OH) concentrations are also associated with lower bone mineral density.
The results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings.
Dr.Jacinthbabu MD., (Path)
Consultant Pathologist
END OF THE REPORT